Super flop ipo better to buy in secondary market. Like. Ptc financial. Ireda. Tata tech Asian paints hdfc bank available at lower prices
92. R.A.| Link| Bookmark|
February 12, 2024 4:50:48 PM
Top Contributor (300+ Posts, 100+ Likes)
I wish this IPO could not complete minimum subscription of 90%. So that either company have to reduce it's IPO size to make it successful of have to withdraw.
Nowadays.. Every thing settled before ipo announcement..Lead manager & banks provides guarantee for minimum subscription.. against the heavy fee charge by them.. So neither the chance of price reduction.. Nor the date extention.. Qib will apply heavily in Hni.. To acquire maximum reserved hni shares & unsubscribe portion of Retail.. If any remains, will also be distributed to them.. around 90℅ holding will be with qib+Anchors hands.. Looking to this situation.. This share can surprise on listing.. These are my personal views only.. I may be wrong totally.. Because share market is always unpredictable..!!
No profits in last three years, meagre subscription levels (18% after 2nd day of IPO), GMP close to zero, expensive valuations, fake promoting attempts .... what else one need to make decision for applying/avoiding? Any thoughts 💭
Is this a sponsored article, CG guys? I remember a similar article was up during AGS Transact's IPO in CG. AGS Transact listed flat, then crossed IPO price once, and is now languishing at sub-100 levels, with an LC today.
Ads are fine and it's routine here but the article seems fishy. I would have expected a "sponsored" tag.
Always in restraint of Mrs. Crow.
89.4. SANJEEV SOOD| Link| Bookmark|
February 12, 2024 3:19:20 PM
Top Contributor (300+ Posts, 100+ Likes)
This is called, make hay while sun shines , who else but CHEE BUSINESS guest analysts , can vouch for it. I cautioned everyone , not to subscrive to Italian Edible ( Appx. 200 times oversubscribed ). There is a saying in stock markets , Fools and their money will part ways soon . Let us see how many of us , will hold aloft this Idiom.
जो नए यूजर Paid Promotion के लिए प्रकट हुए है उनके लिए : अपने paid promotion वाला पैसा इधर लगाओ यदि कॉन्फिडेंस है तो, फिर शायद थोड़ा सब्सक्रिप्शन फिगर ऊपर हो जाए 😆
If the issue is more than 90% subscribed but not fully subscribed, all investors will receive the full allocation. The issuer may extend the deadline for closing the issue and reduce the issue price. The issuer may reduce the Offer for Sale portion of the issue. If issue fails to subscribe 90%, there is option fot it to get cancelled and bid amount needs to be returned to applicants.
86. Chhote Lal| Link| Bookmark|
February 12, 2024 11:35:49 AM
IPO Mentor (6100+ Posts, 4500+ Likes)
For Retail Segment, total no. shares offered should be 1,265,501 (9.5%) and not 1,898,251 (14.21%) as appearing in this page on chittorgarh.com As per rules, retail segment quota in such a company (negative profit in last three years) CAN'T be more than 10%. @Admin @ Chittorgarh.com Request you to clarify.
@Admin @ Chittorgarh.com There is big discrepancy observed in Subscription Data table of CG.com with respect to total no. of shares offered for all the categories and not just the Retail Segment, when verified with Bid Details given in official websites of NSE and BSE.
This makes the subscription figures v/s the total offered completely wrong and misleading.
Request you verify it yourself and re-upload correct data.
As per Canara Bank Securities "Entero Healthcare Solutions emerges as a prominent player in India's healthcare distribution sector, boasting rapid expansion and a diverse product portfolio. Despite these strengths, notable weaknesses and risks deter a positive investment stance. The company reported consistent losses, grapples with negative cash flows, and engages in an uncertain spree of acquisitions, raising financial concerns. Operating in a capital-intensive sector, Entero faces challenges in maintaining optimal working capital, with a substantial Rs 782.65 crore as of September 30, 2023. Pledging 100% shares in subsidiaries and regulatory compliance issues pose potential threats. Legal proceedings, including criminal cases, and exposure to inventory risks further heighten apprehensions. Entero's profit margins are vulnerable to supplier trade discount fluctuations. Given the uncertainties and significant risks associated with the company's financial health, regulatory compliance, and operational aspects, we suggest to exercise caution, and therefore, we recommend avoiding this IPO for now."
@Admin @ Chittorgarh.com@Prachi @ Team Chittorgarh.com Article for Entero Health "Why Entero Healthcare is a must-have for investors in their portfolio?" as link is available on CG portal is promotion or anything. Please clarify.
81. whiteFox| Link| Bookmark|
February 12, 2024 8:02:28 AM
IPO Mentor (600+ Posts, 200+ Likes)
Better to buy after listing
81.1. The Nest| Link| Bookmark|
February 12, 2024 12:16:58 PM
Top Contributor (300+ Posts, 200+ Likes)
@Basuvr Yesterday, there were a dozen odd such new entrants were found in this page and were rightly shown the door. Few have comeback again. But nothing to worry, our CG community members are mature enough to fall prey to any trap. Request @Admin @ Chittorgarh.com to continue taking required action promptly. Forum's purpose and values can not be allowed to get compromised by any cheap tactics.
Only thing I want to emphasise is don't get lost in the negativity.
Significant revenue bump would be expected since much of the fresh issue will go towards acquisitions and FY25 and FY26 cagr could be much more than historic and also can apportionate some of the expenses like in any scale focussed business leading to better profitability. So better to look at the FY25 eps for making decisions on whether the company is worth investing.
Also we shouldn't forget the great anchors who have puy large cheques. Hopefully some good due diligence would have been done by them before putting such large money.
I would apply tomorrow once I look at the qib portion. Lets see.
शेयर बाजार में उतना ही निवेश करें, जितना आप उठा सकें नुकसान। और कभी भी किसी की बातों में आकर शेयर ना खरीदें और बेचें, अपनी खुद की रिसर्च करें और उसके बाद ही लें कोई भी फैसला...
This one is a Big barsaati Mendak. Look at the EPS and PE of the share. Look at the PAT in previous years and then only apply. People with very little knowledge and huge money are entering the market for quick profits. Look at the subscription data of SME ipos. Past 20yrs of my experience tells me the way things are going small investors are going to loose huge money. Posting my first msg though watching and reading this site for last 6-7yrs.